The Fourth Generation CART-cell Therapy for Refractory-Relapsed Ovarian Cancer

NCT03814447 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: anti- MESO CAR-T cells
DRUG: Fludarabine
DRUG: Cyclophosphamide

Sponsor

Shanghai 6th People's Hospital

Collaborators

[object Object]